CLINICAL

Development Soars for Alzheimer’s DrugsThere is lots of room for both success and failure in the Alzheimer's drug market.
How Should Opioid Addiction Be Treated?As the opioid crisis worsens, debates rage about the best methods to combat it.
Generics Market Expected to Explode in Next Five YearsThe U.S. market remains the largest single-country market in the world.
Abuse-Deterrent Opioid Rexista Makes Misusers Blue—LiterallyHow one opioid abuse deterrent could make it easy to identify misuse.
Safinamide (Xadago): Approved as Add-On for Parkinson’sXadago has been approved as a supplementary medication for patients with Parkinson's disease who are having "off" episodes or whose disease is progressing.
FDA Orders Stop Sale of PainkillerThe first opioid taken off the shelves because of potential abuse.
Staff Burnout Rates are High at Pharmacy SchoolsA study found that pharmacy practice faculty experience high rates of emotional exhaustion.
Where Are the New Antibiotics?With the threat of superbugs and the possibility of an antibiotic-less future, alternatives are needed now.
Pharmacy Groups Warn Trump About Drug ImportsNACDS and APhA warn that letting Americans buy foreign drugs could be disastrous.
Cancer Drug Spending SoarsNew therapies and increased awareness lead to a large market.

Poll